Each day AAHP works to promote excellence in the practice of homeopathic manufacturing. While achieving true excellence is a lofty goal, it begins with a few simple principles you can start to implement today.

We’ve reviewed recent Warning Letters from the U.S. FDA—which highlight some of the most common missteps and shortcomings—and have put together these four basic ground rules that can help any homeopathic manufacturer or marketer strive toward excellence.

What’s Your Company’s Safety Statistics?   When FDA announced its public hearing on homeopathy, the agency cited 10,311 reported poison exposure cases related to “homeopathic agents” in the 2012 American…

By Eric L. Foxman, R.Ph., senior scientist, HPCUS Homeopathic pharmacopoeias have been published continually since the 1840s. The Homeopathic Pharmacopoeia of the United States (HPUS) has been in continuous publication…

By Eric L. Foxman, R.PH., AAHP Secretary Of all the Warning Letters issued by the FDA, very few go to homeopathic manufacturers or marketers. That’s good. On the other hand,…